SCHEMBL18511441

SCHEMBL18511441

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-n4c5ccccc5c5cc(N(c6ccccc6)c6ccc7c(c6)c6ccccc6n7-c6ccc(-c7nc(-c8ccccc8)nc(-c8ccccc8)n7)cc6)ccc54)cc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
ATM Q13315 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
RAC2 P15153 1/20 0.38
RAC3 P60763 1/20 0.38
CDC42 P60953 1/20 0.38
RAC1 P63000 1/20 0.38
PTGER4 P35408 1/20 0.38
MAPT P10636 4/20 0.35
HPGD P15428 3/20 0.35
ALDH1A1 P00352 3/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
PDE5A O76074 2/20 0.35
LMNA P02545 2/20 0.35
TSHR P16473 2/20 0.35
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15785783 1.00 KDM4E (0.42) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL15785785 0.99 KDM4E (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL17897444 0.99 KDM4E (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL18565219 0.99 KDM4E (0.44) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL18511422 0.97 KDM4E (0.42) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL18511442 0.97 KDM4E (0.42) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL18511444 0.97 KDM4E (0.42) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL18511454 0.97 KDM4E (0.45) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL18565233 0.96 KDM4E (0.47) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL15785790 0.96 MAPT (0.36) KDM4EATML3MBTL1RAC2RAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10043981-B2 Light-emitting material, organic light-emitting device, and compound KYULUX, INC. (JP) 2018-08-07 US disclosed
US-10043981-B2 Light-emitting material, organic light-emitting device, and compound KYULUX, INC. (JP) 2018-08-07 US disclosed
US-20170338418-A1 LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND KYULUX, INC. (JP) 2017-11-23 US disclosed
US-20170338418-A1 LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND KYULUX, INC. (JP) 2017-11-23 US disclosed
US-9773982-B2 Light-emitting material, organic light-emitting device, and compound KYULUX, INC. (JP) 2017-09-26 US disclosed
US-9773982-B2 Light-emitting material, organic light-emitting device, and compound KYULUX, INC. (JP) 2017-09-26 US disclosed
US-20170047522-A1 LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND KYULUX, INC. (JP) 2017-02-16 US disclosed
US-20170047522-A1 LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND KYULUX, INC. (JP) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10043981-B2 Light-emitting material, organic light-emitting device, and compound GRK1, ARL1, NR2E3 KDM4E 3726/4885ATM 1646/4885L3MBTL1 653/4885
US-20170047522-A1 LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND GRK1, ARL1, NR2E3 KDM4E 3726/4885ATM 1646/4885L3MBTL1 653/4885
US-20170338418-A1 LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING DEVICE, AND COMPOUND GRK1, ARL1, NR2E3 KDM4E 3726/4885ATM 1646/4885L3MBTL1 653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.